WordNet

not exerting influence or change
not in physical motion; "the inertia of an object at rest" (同)motionless, static, still
(chemistry) not participating in a chemical reaction; chemically inert; "desired amounts of inactive chlorine"
(pathology) not progressing or increasing; or progressing slowly
lacking activity; lying idle or unused; "an inactive mine"; "inactive accounts"; "inactive machinery"
not active physically or mentally; "illness forced him to live an inactive life"; "dreamy and inactive by nature"
not engaged in full-time work; "inactive reserve"; "an inactive member"
being long-lasting and recurrent or characterized by long suffering; "chronic indigestion"; "a chronic shortage of funds"; "a chronic invalid"
of long duration; "chronic money problems" (同)continuing
habitual; "a chronic smoker" (同)inveterate
inflammation of the liver caused by a virus or a toxin

PrepTutorEJDIC

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. B型肝炎のマネージメントの概要および症例 overview of the management of hepatitis b and case examples
2. 小児および思春期におけるB型肝炎ウイルス感染の概要 overview of hepatitis b virus infection in children and adolescents
3. B型肝炎ウイルス感染の臨床症状および自然経過 clinical manifestations and natural history of hepatitis b virus infection
4. B型肝炎ウイルス感染の診断 diagnosis of hepatitis b virus infection
5. 慢性C型肝炎ウイルス感染のマネージメントの概要 overview of the management of chronic hepatitis c virus infection

Yu F1, Yang J2, Ouyang J3, Zheng Y4, Chen B5, Li G6, Lu Z7, Dong P8, Zheng J9.
Clinica chimica acta; international journal of clinical chemistry.Clin Chim Acta.2015 Oct 23;450:203-9. doi: 10.1016/j.cca.2015.08.022. Epub 2015 Aug 28.
BACKGROUND: It has been reported that hepatitis B virus (HBV) replication can be suppressed by microRNA-210 (miR-210). However, whether serum miR-210 levels can serve as disease parameters in patients with chronic hepatitis B (CHB) remains unclear.METHODS: Serum miR-210 levels were quantified in 115
PMID 26319884

Association of serum gamma-glutamyl transferase with treatment outcome in chronic hepatitis B patients.

Huang R1, Yang CC1, Liu Y1, Xia J1, Su R1, Xiong YL1, Wang GY1, Sun ZH1, Yan XM1, Lu S1, Wu C1.
World journal of gastroenterology : WJG.World J Gastroenterol.2015 Sep 14;21(34):9957-65. doi: 10.3748/wjg.v21.i34.9957.
AIM: To investigate the association of serum gamma-glutamyl transferase (GGT) levels with chronic hepatitis B infection and hepatitis B e antigen (HBeAg) seroconversion.METHODS: A retrospective study was performed on clinical data collected from patients who had been positive for hepatitis B surface
PMID 26379400

Chronic hepatitis B: Virology, natural history, current management and a glimpse at future opportunities.

Gish RG1, Given BD2, Lai CL3, Locarnini SA4, Lau JY5, Lewis DL2, Schluep T2.
Antiviral research.Antiviral Res.2015 Sep;121:47-58. doi: 10.1016/j.antiviral.2015.06.008. Epub 2015 Jun 16.
The host immune system plays an important role in chronic hepatitis B (CHB), both in viral clearance and hepatocellular damage. Advances in our understanding of the natural history of the disease have led to redefining the major phases of infection, with the "high replicative, low inflammatory" phas
PMID 26092643

Serum Decoy Receptor 3 Is a Useful Predictor for the Active Status of Chronic Hepatitis B in Hepatitis B e Antigen-Negative Patients

Hou Yanqiang,Xu Ping,Lou Xiaoli,Liang Dongyu,Zhang Mei,Zhang Zhenhuan,Zhang Lurong
The Tohoku Journal of Experimental Medicine 230(4), 227-232, 2013
… Hepatitis B virus (HBV) infection is a global public health problem, because patients with chronic hepatitis B (CHB) may progress to liver cirrhosis and eventually evolve into hepatocellular carcinoma. … In this study, we explored the clinical value of serum DcR3 in predicting the active status of CHB in hepatitis B e antigen-negative patients (active HBeAg (−) CHB), which was determined with ELISA. …
NAID 130004460079

牧野祐紀,井倉技,今井康陽,福田和人,澤井良之,小来田幸世,上ノ山直人,土井喜宣,木曽真一,平松直樹,田村信司,林紀夫,竹原徹郎
日本消化器病學會雜誌 = The Japanese journal of gastro-enterology 109(7), 1223-1229, 2012-07-05
30歳男性．13歳時に先天性肝線維症と診断され経過観察中，胃静脈瘤加療および脳死肝移植適応評価目的にて入院した．入院後の肝生検にて13歳時に比べさらに肝線維症の進行を認めた．また精神遅滞，小脳失調，小脳虫部低形成，脈絡膜欠損を認めCOACH症候群と診断した．COACH症候群は過去数十例の報告しかない極めてまれな疾患で，成人後に診断され肝線維症の進行を組織学的に追跡し得た点でも貴重な症例である．
NAID 10030803131

姜貞憲,瀧山晃弘,桜井康雄 [他],松居剛志,金俊文,志田勇人,辻邦彦,児玉芳尚,安保義恭,篠原敏也,真口宏介
肝臓 53(2), 90-100, 2012-02-25
症例は70歳男性で，68歳時，後に肝過形成結節と診断された肝腫瘤精査目的で当院へ紹介された．HBV感染指標からB型肝炎ウイルス（HBV）遺伝子型Aeの持続感染による非活動性carrierと診断し，既往・生活歴と画像診断から非アルコール性脂肪性肝疾患の合併を疑った．経過観察から2年後，肝S6に直径20 mm大の新たな腫瘤性病変を認めたため血管造影CT等で精査を行い肝細胞癌（臨床病期II，肝障害度A） …
NAID 10030240973